Other case reports

Case report 1 - The use of LIGASANO® orange in skin transplants

Patient data and anamnesis:

2-year-old boy from Ecuador with a severe polytrauma. Traffic accident on 15.08.2015 with severe facial skull fractures, absence of the right eye and absence of most of the midface. The boy comes with a PEG probe and a tracheostoma. Several operations were performed: The scapula flap was removed from the back. The defect was treated with a split skin transplant.

Abb. 1: Versorgung des Defekts mit Spalthaut
Abb. 2: Transplantationsstelle mit Wundabstandsgitter
Abb. 3: Versorgung des Hautransplantats mit Wundabstandsgitter und LIGASANO® orange
Abb. 4: Entfernen von LIGASANO® orange und Wundabstandsgitter
Abb. 5: Entferntes LIGASANO® orange und Wundabstandsgitter
Abb. 6: Eingeheiltes Transplantat nach einem Jahr

In order to ensure the safe healing of skin grafts, they require a constant pressure on the underlying tissue. On the one hand, shear forces between the graft and the wound bed must be avoided in order to prevent the newly ingrown capillaries from shearing, and on the other hand, the skin must be compressed to prevent oedema in the graft. 

Both can only be achieved through a certain strength of the PUR foam used, which must be attached to the surrounding tissue on the day of surgery by suture or skin clasps, depending on the indication. In order to avoid direct contact of this foam with the transplanted skin and to prevent adhesions, we use a wound spacing grid as a base. The compression bandage is left for 5-7 days, after which it can be carefully removed. The graft is then so far stable and can either only be treated with wound spacers and compresses, or again with a compression bandage using the PUR foam bandage LIGASANO® orange, which only needs to be fixed to the wound by wrapping or adhesive strips. From this point on, we recommend changing the dressing every two days. 

Based on our experience to date, LIGASANO® orange from the company LIGAMED® is to be favoured here because of its properties. A compression by LIGASANO® green would also be conceivable. 

Authors: Dr. med. André Borsche, Dr. med. Mathis Renner and Sabine Herler, Diakonie-Krankenhaus Bad Kreuznach

Case report 2 - Wound treatment with LIGASANO® for inflamed PEG puncture site

Patient data and anamnesis:

2-year old girl from Lower Bavaria, Z.n. epileptic encephalopathy, a PEG plant due to refusal to eat was carried out on 05.09.2016 in Augsburg. First daily bandage change, cleaning with NaCl, supply with Metalline.

Inflammation of the injection site, pus focus visible, swollen. Presentation at the paediatrician. Recommendation: Change of dressing twice a day, cleaning with Octenisept, if necessary antiobiotic ointment in case of further deterioration. From 14.09.2016 Start of treatment with LIGASANO®: Cleaning twice daily with Octenisept, application of a sterile LIGASANO® slotted compress 7.5 x 7.5 x 1 cm.

Abb. 1: 16.09.2016 Reinigung mit Octenisept, Applikation von Antibiotikasalbe für zwei Tage, Verbandwechsel einmal täglich mit LIGASANO® weiß steril 7,5 x 7,5 x 1 cm
Abb. 2: 23.09.2016 Deutliche Besserung, weiterhin Verbandwechsel einmal täglich mit LIGASANO® weiß steril 7,5 x 7,5 x 1 cm, Salbenversorgung beendet.
Abb. 3: 10.10.2016 Noch minimale Entzündung vorhanden, weiterhin Verbandwechsel einmal täglich mit LIGASANO® weiß steril 7,5 x 7,5 x 1 cm
Abb. 4: 23.10.2016 vollständige Abheilung der Entzündung.
Abb. 5: 23.10.2016 Weiterhin Anwendung der Schlitzkompresse aus LIGASANO® weiß steril 7,5 x 7,5 x 1 cm


A very simple, inexpensive and allergen-free supply. The slit compresses made of LIGASANO® white dressing material are still used as pressure protection and prophylaxis.


Author: Barbara Hinz, nurse, wound expert, from Landshut, Germany

Case report 3: Wound treatment with LIGASANO® for abscessing sinus pilonidalis

Patient data / anamnesis:

33 years, male, abscessing sinus pilonidalis (recurrence), condition after excision, open wound treatment in November 2014 with abscess left lateral to the penis root, condition after excision, open wound treatment in April 2013 with abscessing sinus pilonidalis, condition after pit-picking, nicotine abuse. In September 2015 an excision of the abscessing pilonidal sinus was performed. Histological findings: Pilonidal sinus with florid and chronic fibrosing inflammation. Pretreatment in the clinic: Several times daily showering of the wound. Treatment with compresses was performed as wound filler and wound covering. A Fixomull® stretch polyacrylate adhesive plaster was used for fixation.

The patient presented for the first time on 27 October 2015 at our WZ® Wound Centre with severe pain in the area of the wound and wound environment under drug pain therapy with Cox-2 inhibitor - Arcoxia 90 mg in the morning. The wound environment showed no signs of irritation. There was a slight bleeding in the area of the wound margin.

The wound depth was 2.5 cm up to the subcutis. 80% of the wound bed was covered with fibrin, which was strongly attached to the wound bed. Isolated granulation islands appeared. A wound odour was present when the dressing was removed. A wound swab was taken at first admission with the finding of colonisation by Corynebacterium sp. and coagulase-negative staphylococci. On 29.03.2016 a control smear was taken, in which only isolated erythrocytes, leukocytes and epithelial cells were found. The local therapeutic wound treatment in the WZ® Wound Centre was carried out as follows:

Wound cleaning: Wet-dry phase with a wound cleansing solution based on a singlet oxygen, NaOCl (ActiMaris®).

Wound filler: Tamponade with LIGASANO® Wound strip 300 x 2.5 x 0.4 cm, white, sterile.

Wound coverage: Zetuvit® plus10 x 20 cm. Fixation with Mefix® 11 cm x 10 m.

Frequency of dressing changes daily, with exudate removal 3-4 x weekly. Relatives were instructed on dressing changes. In the context of the reduction of patient relatives, particular emphasis was placed on hygienic measures, nicotine refusal, pain medication intake and nutritional substitution. A seat cushion was prescribed as an aid to reduce or distribute pressure.

Abb. 1: 27.10.2015
Abb. 2: 17.11.2015
Abb. 3: 03.12.2015
Abb. 4: 22.12.2015
Abb. 5: 14.01.2016

Fig. 1: 27.10.2015: Wound size 8.37 cm2, wound depth 2.5 cm, pain according to NRS: 8/10 

Fig. 2: 17.11.2015: Wound size: 4.35 cm2. Wound contraction visible, epithelial tissue in the wound area is stable. Wound depth: 1.8 cm. Due to the local therapeutic measure with the LIGASANO® wound dressing used, white, sterile, pain reduction could be achieved according to NRS: 3/6. 

Fig. 3: From 03.12.2015 a change in therapy was performed. Wound cleansing was left untreated, the absorber was replaced by a LIGASANO® wound dressing. Fixation remained. Frequency of dressing changes increased to 4x weekly. 

Fig. 4: 22.12.2015: Wound size 0.31 cm2, wound depth 0.1 cm, pain medication discontinued since 14.12.2015. 

Fig. 5: 14.01.2016: Stable, epithelialized wound, recurrence-free until August 2016. 


Summary / Conclusion:

The LIGASANO® Wound Tape 300 x 2.5 x 0.4 cm, white, sterile shows a very good adaptation to the wound contours without exerting pressure on the wound. Granulation and wound contraction took place very quickly with simultaneous reduction of exudation and significant pain reduction. 


Author: Heidi Jodl, health and nurse, AZWM®, head of the WZ® Wound Center Augsburg